BYMAA LABORATORIES is a professionally managed company founded in 2011, based in India. The company is focused on the manufacturing and exporting of pharmaceutical products with a specialization in pharmaceutical generics, antibiotics, dental, and dermatology products. Their product range includes high-end pharmaceutical formulations such as imipenum/Cilastatin, meropenem, Piperacillin/Tazobactum, and aztronam, catering to international markets.
Their commitment to delivering quality products within specified timelines sets them apart in the Health Care and Pharmaceutical industries. Currently, there is no public record of their last investment or the investors involved. However, the company's strategic focus on high-end pharmaceuticals and its presence in the growing Indian pharmaceutical market presents potential investment opportunities.
There is no investment information
No recent news or press coverage available for BYMAA LABORATORIES.
We care about your data, and we'd love to use cookies make your experience better.
